**Chapter 6**

*Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications*

Clinical Therapeutics. 2016;**38**:688-701. DOI: 10.1016/j.clinthera.2015.12.001

[101] Eisenstein M. Big data: The power of petabytes. Nature. 2015;**527**:S2-S4.

DOI: 10.1038/527S2a

[92] van Rooy I et al. In vivo methods to study uptake of nanoparticles into the brain. Pharmaceutical Research. 2011;**28**:456-471. DOI: 10.1007/

[93] Reichel A. Addressing central nervous system (CNS) penetration in drug discovery: Basics and implications of the evolving new concept. Chemistry & Biodiversity. 2009;**6**:2030-2049. DOI:

[94] Bonate PL. Animal models for studying transport across the bloodbrain barrier. Journal of Neuroscience

[95] Artursson P. Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. Journal of Pharmaceutical Sciences. 1990;**79**:476-482. DOI: 10.1002/

Methods. 1995;**56**:1-15. DOI: 10.1016/0165-0270(94)00081-q

jps.2600790604

minf.200900069

10.1586/ecp.12.74

[98] Reddy AS, Zhang S.

[96] Raju TN et al. Lancet. 2000;**355**:1022. DOI: 10.1016/ s0140-6736(05)74775-9

[97] Vogt I, Mestres J. Drug-target networks. Molecular Informatics. 2010;**29**:10-14. DOI: 10.1002/

Polypharmacology: Drug discovery for the future. Expert Review of Clinical Pharmacology. 2013;**6**:41-47. DOI:

[99] Yildirim MA, Goh KI, Cusick ME, Barabási AL, Vidal M. Drug-target network. Nature Biotechnology. 2007;**25**:1119-1126. DOI: 10.1038/

[100] Chen Y, Elenee Argentinis JD, Weber G. IBM Watson: How cognitive computing can be applied to big data challenges in life sciences research.

s11095-010-0291-7

10.1002/cbdv.200900103

**96**

nbt1338
